Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330940 · ClinicalTrials.gov registry record · NA
Effect of Diet Orange Soda on Urinary Lithogenicity
A NA study of Nephrolithiasis and Kidney Stones, sponsored by VA New York Harbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT01330940 is a NA study of Nephrolithiasis and Kidney Stones that has completed, run by VA New York Harbor Healthcare System. The registered enrollment target is 12 participants, below the 124-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01330940, a NA study of Nephrolithiasis and Kidney Stones, has completed, sponsored by VA New York Harbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Beverages containing citrate may be useful in increasing urine citrate content and urine pH. Such changes in urine chemistry could help prevent kidney stones. Diet orange soda has more citrate than other similar beverages. The investigators are interested in whether diet soda will improve urine chemistry in the appropriate manner.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Orange soda
Study Locations (1)
New York
- New York Harbor VA Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01330940
The ClinicalTrials.gov registry entry for NCT01330940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 124-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (90% lower). The listed sponsor is VA New York Harbor Healthcare System, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which Orange soda is the first listed.
NCT01330940 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01330940 about?
NCT01330940 is a clinical study titled "Effect of Diet Orange Soda on Urinary Lithogenicity". Beverages containing citrate may be useful in increasing urine citrate content and urine pH. Such changes in urine chemistry could help prevent kidney stones. Diet orange soda has more citrate than other similar beverages. The investigators are interested in whether diet soda will improve urine chem...
What is the current status of trial NCT01330940?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-11. Estimated completion is 2010-07.
What conditions does trial NCT01330940 study?
This clinical trial studies the following conditions: Nephrolithiasis, Kidney Stones, Urolithiasis.
What interventions are being tested in trial NCT01330940?
The interventions under investigation include: Orange soda (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01330940?
This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01330940 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.